Alterity Therapeutics (ATHE) Assets Average (2015 - 2025)

Alterity Therapeutics has reported Assets Average for 11 years, with the latest figure at $33.4 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average rose 241.65% year-over-year to $33.4 million; the trailing twelve-month figure through Dec 2025 stood at $33.4 million (up 241.65% YoY), and the FY2023 full-year result was $9129.0 billion, up 32903459.44% from the prior year.
• Assets Average for Q4 2025 stood at $33.4 million, up from $18.2 million in the prior quarter.
• The five-year high for Assets Average was $33.4 million in Q4 2025, with the low at $7.4 million in Q4 2023.
• Average Assets Average over 5 years is $20.6 million, with a median of $22.0 million recorded in 2022.
• Year-over-year, Assets Average tumbled 71.45% in 2023 and soared 241.65% in 2025.
• Tracing ATHE's Assets Average over 5 years: stood at $29.3 million in 2021, then fell by 12.01% to $25.8 million in 2022, then tumbled by 71.45% to $7.4 million in 2023, then surged by 32.92% to $9.8 million in 2024, then soared by 241.65% to $33.4 million in 2025.
• The last three Assets Average figures came in at $33.4 million (Q4 2025), $18.2 million (Q2 2025), and $9.8 million (Q4 2024), per Business Quant data.

Peer Comparison